MAY 09, 2020 9:55 AM PDT

Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads

WRITTEN BY: Carmen Leitch

The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem for officials that are trying to get a handle on the disease and reopen states. We know that the virus causes an illness called COVID-19 in some of the people that are infected, but in many cases, no symptoms are present even though a person is infected and contagious. This has helped contribute to the spread of the disease (explained in the video below), since testing has been limited mostly to just symptomatic people.

We know how to diagnose a viral infection when we know the genomic sequence of the virus, and we have that information for SARS-CoV-2; the most straightforward way to test for it is to look for the genomic material from the virus in a patient sample. In the case of SARS-CoV-2, the genome is made of RNA. A method called PCR can be used to detect the viral genome by amplifying it with short strands of DNA that match the viral genome sequence. But in order to do that, RNA must first be extracted from the sample that is being tested, like a tube of patient blood.

RNA extraction can be accomplished relatively quickly in a typical molecular laboratory using either chemical extraction methods that require a special reagent, or by passing the sample through a column, which is then treated with reagents to purify the RNA before it is released from the column. But to address the pandemic, tens of millions of tests are now needed, creating a major bottleneck.

Researchers at Cima Universidad de Navarra have now found a way around this problem. They engineered a test that uses magnetic beads to rapidly pull the RNA out of a sample.

"Normally, commercial test kits require a manual extraction procedure, based on the use of columns and centrifuges. With our system, the extraction of RNA is done on 96-well plate samples. No centrifugation is needed because we use magnetic beads that bind RNA. That allows researchers to use a magnet that draws the beads to the side of the tube and quickly purifies the RNA from many samples automatically," explained Dr. Lara-Astiaso, director of the Genomics Unit at Cima Universidad de Navarra.

This RNA can then be used to generate a template that is used in a diagnostic PCR reaction. This method can detect both symptomatic and asymptomatic cases, which can help in addressing hotspots that arise after the first wave of the pandemic has subsided.

The diagnostic pipeline created by Cima researchers is highly sensitive, efficient, and can be used on a large scale. RNA can be extracted from many samples in parallel, and the scientists report that the sensitivity of the test in detecting asymptomatic infections is over 95 percent.  The protocol has been made freely available. The method is also used in a PCR reaction that is quantitative (known as qRT-PCR), which can also reveal the level of viral particles in a sample. The researchers were able to process 384 samples in about two hours.

We still don't know whether people that recover from an infection will be immune to future infections. "We have to ensure that large populations can be tested using PCR high-efficiency platforms like ours. This is a crucial element to prevent a re-emergence or second wave of COVID," said Dr. Josepmaría Argemí, a researcher at Cima and a Hepatology specialist at Clinica Universidad de Navarra.

"A team of four Cima scientists can currently analyze 1,920 samples a day, but these numbers can be scaled based on the available PCR machines and with only a few more staff. Another great advantage of this process is that the amount of reagents used is lower than the usual COVID detection protocols," added Argemí.

Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

Sources: AAAS/Eurekalert! Via Universidad de Navarra

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 06, 2020
Clinical & Molecular DX
Device Diagnoses Breast Cancer in 60 Minutes
AUG 06, 2020
Device Diagnoses Breast Cancer in 60 Minutes
Researchers have created a point-of-care device that can provide diagnostic results for breast cancer in under an hour. ...
SEP 02, 2020
Clinical & Molecular DX
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
SEP 02, 2020
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
Yawning in the middle of the day is completely normal for people with hectic schedules. How do you know whether it&rsquo ...
OCT 27, 2020
Clinical & Molecular DX
A Super Sensitive Alzheimer's Test Powered by Nanozymes
OCT 27, 2020
A Super Sensitive Alzheimer's Test Powered by Nanozymes
  Simple tasks are now uphill struggles, social situations aren’t fun, and the car keys are missing again. By ...
OCT 29, 2020
Clinical & Molecular DX
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
OCT 29, 2020
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
 
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
Loading Comments...